Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate for Uncomplicated Malaria in Mozambican Children
NCT04370977Phase 4Completed
- Sponsor
- Manhiça Health Research Centre
- Start
- Mar 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artemether + lumefantrine and artesunate + amodiaquine in Malaria (2 arms), sponsored by Manhiça Health Research Centre. Primary endpoint: Day 28 PCR corrected cure rates. Started Mar 2018; status: completed.
02
Drugs
artemether + lumefantrineartesunate + amodiaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT04370977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04370977.